NFKB1 and neoplasm: It also provides a theoretical foundation for identifying appropriate combination therapies utilizing vasculature‐homing tools (Lu et al, 2017) to target autophagy inhibitors or NF‐κB modulators (Lalle et al, 2021) to the tumor vasculature.